{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:23:54Z","timestamp":1790000634678,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T00:00:00Z","timestamp":1444608000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1700-4","type":"journal-article","created":{"date-parts":[[2015,10,12]],"date-time":"2015-10-12T22:51:57Z","timestamp":1444690317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation"],"prefix":"10.1186","volume":"15","author":[{"given":"Arantzazu","family":"Arrospide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Rue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolien T.","family":"van Ravesteyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merce","family":"Comas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Larra\u00f1aga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garbi\u00f1e","family":"Sarriugarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,12]]},"reference":[{"key":"1700_CR1","volume-title":"Principles and practice of screening for disease. Public Health Papers 34","author":"JM Wilson","year":"1968","unstructured":"Wilson JM, Jungner G. Principles and practice of screening for disease. Public Health Papers 34. Geneva: World Health Organisation; 1968."},{"key":"1700_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1258\/jms.2012.012082","volume":"19 Suppl 1","author":"D Puliti","year":"2012","unstructured":"Puliti D, Duffy SW, Miccinesi G, De Koning H, Lynge E, Zappa M, et al. Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review. J Med Screen. 2012;19 Suppl 1:42\u201356.","journal-title":"J Med Screen"},{"key":"1700_CR3","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","volume":"359","author":"L Nystr\u00f6m","year":"2002","unstructured":"Nystr\u00f6m L, Andersson I, Bjurstam N, Frisell J, Nordenskj\u00f6ld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909\u201319.","journal-title":"Lancet"},{"key":"1700_CR4","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/cncr.11361","volume":"97","author":"N Bjurstam","year":"2003","unstructured":"Bjurstam N, Bjorneld L, Warwick J, Sala E, Duffy SW, Nystrom L, et al. The Gothenburg Breast Screening Trial. Cancer. 2003;97:2387\u201396.","journal-title":"Cancer"},{"key":"1700_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/1471-2407-13-587","volume":"13","author":"A Arrospide","year":"2013","unstructured":"Arrospide A, Forne C, Rue M, Tora N, Mar J, Bare M. An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain. BMC Cancer. 2013;13:587.","journal-title":"BMC Cancer"},{"key":"1700_CR6","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/bjc.2013.259","volume":"108","author":"AL Harris","year":"2013","unstructured":"Harris AL. Breast screening remains a controversial issue. Br J Cancer. 2013;108:2197.","journal-title":"Br J Cancer"},{"key":"1700_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1158\/1055-9965.EPI-13-0946","volume":"23","author":"RA Smith","year":"2014","unstructured":"Smith RA. The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates. Cancer Epidemiol Biomarkers Prev. 2014;23:1139\u201346.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"21","key":"1700_CR8","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMp1401875","volume":"370","author":"N Biller-Andorno","year":"2014","unstructured":"Biller-Andorno N, Juni MD. Abolishing Mammography Screening Programs? A View from the Swiss Medical Board. N Engl J Med. 2014;370(21):1965\u20137.","journal-title":"N Engl J Med"},{"key":"1700_CR9","volume-title":"D\u00e9pistage syst\u00e9matique par mammographie","author":"N Biller-Andorno","year":"2013","unstructured":"Biller-Andorno N, Cignacco E, Felder S, Juni P, Meier-Abt P, Metzger U, et al. D\u00e9pistage syst\u00e9matique par mammographie. Zollikon: Swiss Medical Board; 2013."},{"issue":"Suppl 1","key":"1700_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/jms.2012.012074","volume":"19","author":"A Hackshaw","year":"2012","unstructured":"Hackshaw A. The benefits and harms of mammographic screening for breast cancer: building the evidence base using service screening programmes. J Med Screen. 2012;19 Suppl 1:1\u20132.","journal-title":"J Med Screen"},{"key":"1700_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0213-9111(11)70004-8","volume":"25","author":"JR Villalbi","year":"2011","unstructured":"Villalbi JR, Tresserras R. Evaluaci\u00f3n de pol\u00edticas y planes de salud. Gac Sanit. 2011;25:17\u201324.","journal-title":"Gac Sanit"},{"key":"1700_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.healthpol.2009.07.012","volume":"93","author":"H Weatherly","year":"2009","unstructured":"Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009;93:85\u201392.","journal-title":"Health Policy"},{"key":"1700_CR13","volume-title":"European guidelines for quality assurance in breast cancer screening and diagnosis. Heath Consumer Protection (ed)","author":"N Perry","year":"2006","unstructured":"Perry N, Broeders M, De Wolf C, T\u00f6rnberg S, Holland R, Von Karsa L. European guidelines for quality assurance in breast cancer screening and diagnosis. Heath Consumer Protection (ed). Luxembourg: Office for Official Publications of the European Communities; 2006."},{"key":"1700_CR14","doi-asserted-by":"publisher","first-page":"e97459","DOI":"10.1371\/journal.pone.0097459","volume":"9","author":"M Comas","year":"2014","unstructured":"Comas M, Arrospide A, Mar J, Sala M, Vilaprinyo E, Hernandez C, et al. Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model. PLoS One. 2014;9:e97459.","journal-title":"PLoS One"},{"key":"1700_CR15","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/bjc.2014.206","volume":"110","author":"NB Gunsoy","year":"2014","unstructured":"Gunsoy NB, Garcia-Closas M, Moss SM. Estimating breast cancer mortality reduction and overdiagnosis due to screening for different strategies in the United Kingdom. Br J Cancer. 2014;110:2412\u20139.","journal-title":"Br J Cancer"},{"key":"1700_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1524-4733.2007.00223.x","volume":"11","author":"K Rojnik","year":"2008","unstructured":"Rojnik K, Naversnik K, Mateovic-Rojnik T, Primiczakelj M. Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia. Value Health. 2008;11:139\u201348.","journal-title":"Value Health"},{"issue":"2","key":"1700_CR17","doi-asserted-by":"publisher","first-page":"e86858","DOI":"10.1371\/journal.pone.0086858","volume":"9","author":"E Vilaprinyo","year":"2014","unstructured":"Vilaprinyo E, Forne C, Carles M, Sala M, Pla R, Castells X, et al. Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PloS One. 2014;9(2):e86858.","journal-title":"PloS One"},{"issue":"7","key":"1700_CR18","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/1097-0142(19901001)66:7<1601::AID-CNCR2820660727>3.0.CO;2-O","volume":"66","author":"GJ Oortmarssen van","year":"1990","unstructured":"van Oortmarssen GJ, Habbema JD, van der Maas PJ, de Koning HJ, Collette HJ, Verbeek AL, et al. A model for breast cancer screening. Cancer. 1990;66(7):1601\u201312.","journal-title":"Cancer"},{"key":"1700_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jval.2012.04.013","volume":"15","author":"J Karnon","year":"2012","unstructured":"Karnon J, Stahl J, Brennan A, Caro JJ, Mar J, Moller J, et al. Modeling using discrete event simulation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--4. Value Health. 2012;15:821\u20137.","journal-title":"Value Health"},{"key":"1700_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/00019053-200826020-00004","volume":"26","author":"JE Stahl","year":"2008","unstructured":"Stahl JE. Modelling methods for pharmacoeconomics and health. Pharmacoeconomics. 2008;26:131\u201348.","journal-title":"Pharmacoeconomics"},{"key":"1700_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0272989X09353946","volume":"30","author":"M Hoyle","year":"2010","unstructured":"Hoyle M, Anderson R. Whose costs and benefits? Why economic evalution should simulate both prevalent and all future incident patient cohorts. Med Decis Making. 2010;30:426\u201337.","journal-title":"Med Decis Making"},{"key":"1700_CR22","volume-title":"Cancer in the Basque Country: Incidence, mortality, survival and their trends","author":"MI Izarzugaza","year":"2010","unstructured":"Izarzugaza MI, Martinez R, Audicana C, Larra\u00f1aga N, Henandez E, Tobalina MC, et al. Cancer in the Basque Country: Incidence, mortality, survival and their trends. Vitoria-Gasteiz: Department of Health and Consumer Affairs, Basque Country Administration; 2010."},{"key":"1700_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/1471-2407-8-331","volume":"8","author":"E Vilaprinyo","year":"2008","unstructured":"Vilaprinyo E, Gispert R, Martinez-Alonso M, Carles M, Pla R, Espinas JA, et al. Competing risks to breast cancer mortality in Catalonia. BMC Cancer. 2008;8:331\u20138.","journal-title":"BMC Cancer"},{"key":"1700_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/jncimonographs\/lgj011","volume":"36","author":"S Lee","year":"2006","unstructured":"Lee S, Zelen M. A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr. 2006;36:79\u201386.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1700_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/1471-2407-9-326","volume":"9","author":"M Rue","year":"2009","unstructured":"Rue M, Vilaprinyo E, Lee S, Martinez-Alonso M, Carles MD, Marcos-Gragera R, et al. Effectiveness of early detection on breast cancer mortality reduction in Catalonia (Spain). BMC Cancer. 2009;9:326\u201335.","journal-title":"BMC Cancer"},{"key":"1700_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2407-9-98","volume":"9","author":"E Vilaprinyo","year":"2009","unstructured":"Vilaprinyo E, Rue M, Marcos-Gragera R, Martinez-Alonso M. Estimation of age- and stage-specific Catalan breast cancer survival functions using US and Catalan survival data. BMC Cancer. 2009;9:98\u2013111.","journal-title":"BMC Cancer"},{"key":"1700_CR27","first-page":"89","volume":"1","author":"A Arrospide","year":"2015","unstructured":"Arrospide A, Soto-Gordoa M, Acaiturri T, Lopez-Vivanco G, Abecia LC, Mar J. The cost of breast cancer treatment by clinical stage in the Basque Country, Spain. Rev Esp Salud P\u00fablica. 2015;1:89\u201393.","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"1700_CR28","unstructured":"Sarriugarte G. Generalidades del Programa de Detecci\u00f3n Precoz de C\u00e1ncer de Mama del Pa\u00eds Vasco [Online]. Departamento de Salud del Gobierno Vasco. 2011. Available in: http:\/\/www.osakidetza.euskadi.net\/r85-ckenfe11\/es\/contenidos\/informacion\/cancer_mama\/es_canc_mam\/generalidades.html . Access date: 5th May 2014."},{"key":"1700_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/11584610-000000000-00000","volume":"29","author":"J Karnon","year":"2011","unstructured":"Karnon J, Vanni T. Calibrating models in economic evaluation. Pharmacoeconomics. 2011;29:51\u201362.","journal-title":"Pharmacoeconomics"},{"key":"1700_CR30","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-69033-9","volume-title":"Steady-State Simulation. Stochastic Simulation: Algorithms and Analysis","author":"S Asmussen","year":"2007","unstructured":"Asmussen S, Glynn P. Steady-State Simulation. Stochastic Simulation: Algorithms and Analysis. New York.: Springer; 2007."},{"key":"1700_CR31","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1038\/bjc.2013.260","volume":"108","author":"N Ormiston-Smith","year":"2013","unstructured":"Ormiston-Smith N, Scowcroft H, Thomson CS. Mortality benefits and overdiagnosis estimates for women attending breast screening. Br J Cancer. 2013;108:2413\u201324.","journal-title":"Br J Cancer"},{"key":"1700_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0140-6736(94)90105-8","volume":"343","author":"R Boer","year":"1994","unstructured":"Boer R, Warmerdam P, De Koning H, Van Oortmarssen G. Extra incidence caused by mammographic screening. Lancet. 1994;343:979.","journal-title":"Lancet"},{"key":"1700_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/epirev\/mxr009","volume":"33","author":"R Gelder De","year":"2011","unstructured":"De Gelder R, Heijnskijk EA, Van Ravesteyn NT, Fracheboud J, Draisma G, De Koning H. Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev. 2011;33:111\u201321.","journal-title":"Epidemiol Rev"},{"key":"1700_CR34","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205\u201340.","journal-title":"Br J Cancer"},{"key":"1700_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1258\/jms.2012.012083","volume":"19 Suppl 1","author":"S Hofvind","year":"2012","unstructured":"Hofvind S, Ponti A, Patnick J, Ascunce N, Njor S, Broeders M, et al. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes. J Med Screen. 2012;19 Suppl 1:57\u201366.","journal-title":"J Med Screen"},{"key":"1700_CR36","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1093\/annonc\/mdt227","volume":"24","author":"JD Otten","year":"2013","unstructured":"Otten JD, Fracheboud J, Den Heeten GJ, Otto SJ, Holland R, De Koning HJ, et al. Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study. Ann Oncol. 2013;24:2501\u20136.","journal-title":"Ann Oncol"},{"key":"1700_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1478-7547-4-14","volume":"4","author":"R Baltussen","year":"2006","unstructured":"Baltussen R, Niessen L. Priority setting of health interventions: the need for multi-criteria decision analysis. Cost Eff Resour Alloc. 2006;4:14\u201322.","journal-title":"Cost Eff Resour Alloc"},{"key":"1700_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/jncimonographs\/lgj015","volume":"36","author":"KA Cronin","year":"2006","unstructured":"Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006;36:112\u201321.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1700_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1258\/jms.2012.012078","volume":"19 Suppl 1","author":"M Broeders","year":"2012","unstructured":"Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19 Suppl 1:14\u201325.","journal-title":"J Med Screen"},{"key":"1700_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2407-11-192","volume":"11","author":"M Carles","year":"2011","unstructured":"Carles M, Vilaprinyo E, Cots F, Gregori A, Pla R, Roman R, et al. Cost-effectiveness of early detection of breast cancer in Catalonia (Spain). BMC Cancer. 2011;11:192\u2013203.","journal-title":"BMC Cancer"},{"key":"1700_CR41","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/bcr3427","volume":"15","author":"SW Duffy","year":"2013","unstructured":"Duffy SW, Parmar D. Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res. 2013;15:R41.","journal-title":"Breast Cancer Res"},{"issue":"23","key":"1700_CR42","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1002\/cncr.27580","volume":"118","author":"AM Yen","year":"2012","unstructured":"Yen AM, Duffy SW, Chen TH, Chen LS, Chiu SY, Fann JC, et al. Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening. Cancer. 2012;118(23):5728\u201332.","journal-title":"Cancer"},{"key":"1700_CR43","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jval.2012.04.012","volume":"15","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB, et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. Value Health. 2012;15:843\u201350.","journal-title":"Value Health"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1700-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1700-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1700-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T07:39:19Z","timestamp":1567237159000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1700-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1700"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1700-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,12]]},"article-number":"671"}}